|
|
 Previous Article | Table of Contents | Next Article 
Expression and Intracellular Localization of the Human N-acetylmuramyl-L-alanine Amidase, a Bacterial Cell Wall-Degrading Enzyme
M.A. Hoijer,
M.J. Melief,
J. Calafat,
D. Roos,
R.W.M. van den Beemd,
J.J.M. van Dongen, and
M.P. Hazenberg
From the Department of Immunology, Erasmus University Rotterdam; the Department of Cell Biology, The Netherlands Cancer Institute, Amsterdam; Central Laboratory of the Netherlands Red Cross Blood Transfusion Service; and the Department of Clinical Immunology, University of Amsterdam, Amsterdam, The Netherlands.
N-acetylmuramyl-L-alanine amidase (NAMLAA) specifically degrades peptidoglycan, which is a major component of bacterial cell walls with strong inflammatory properties. For instance, peptidoglycan is capable of stimulating peripheral blood cells to release pro-inflammatory cytokines and is capable of inducing chronic arthritis in an animal model. In a previous study we found that degradation of peptidoglycan by purified NAMLAA reduced its inflammatory effects. To determine where NAMLAA is located in tissues, monoclonal antibodies against purified NAMLAA were produced for use in immunohistochemistry, immunoelectron microscopy, flow cytometric analysis, and Western blotting. The immunohistochemical studies showed NAMLAA-positive cells in human spleen, liver, arthritic synovial tissues, and lymph nodes. In flow cytometric studies of blood and bone marrow, neutrophilic and eosinophilic granulocytes proved to be positive. Monocytes were negative, although they do contain lysozyme, the other important peptidoglycan-degrading enzyme. However, mature macrophages obtained by bronchoalveolar lavage and subsequent selection based on auto-fluorescence did possess NAMLAA. In immunocytochemical staining of blood smears, thrombocytes were also positive for NAMLAA. Western blot analysis and immunoelectron microscopy of neutrophils and eosinophils showed that NAMLAA is located in azurophilic granules of neutrophils and in secretory vesicles and crystalloid-containing granules of eosinophils. Flow cytometric analysis of blood and bone marrow from different French-American-British-classified acute myeloid leukemia (AML) patients showed that AML-M2 myeloblasts were the first in the granulocyte maturation lineage that were positive for NAMLAA. The more immature AML, such as AML-M0 and AML-M1, did not express NAMLAA. CD15- and CD13-negative megakaryoblasts, corresponding to AML-M7, were also positive for NAMLAA. The expression pattern of NAMLAA in the myeloid lineage suggests that the monoclonal antibody AAA4, recognizing NAMLAA, is useful for discrimination between AML in the monocyte lineage and in the granulocyte lineage.
Blood, Vol. 90 No. 3 (August 1), 1997:
pp. 1246-1254
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L. Visser, M.-J. Melief, D. van Riel, M. van Meurs, E. A. Sick, S. Inamura, J. J. Bajramovic, S. Amor, R. Q. Hintzen, L. A. Boven, et al.
Phagocytes Containing a Disease-Promoting Toll-Like Receptor/Nod Ligand Are Present in the Brain during Demyelinating Disease in Primates
Am. J. Pathol.,
November 1, 2006;
169(5):
1671 - 1685.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Herrmann, M. Kellert, H. Schmidt, A. Mildner, U. K. Hanisch, W. Bruck, M. Prinz, and R. Nau
Streptococcus pneumoniae Infection Aggravates Experimental Autoimmune Encephalomyelitis via Toll-Like Receptor 2.
Infect. Immun.,
August 1, 2006;
74(8):
4841 - 4848.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z.-M. Wang, X. Li, R. R. Cocklin, M. Wang, M. Wang, K. Fukase, S. Inamura, S. Kusumoto, D. Gupta, and R. Dziarski
Human Peptidoglycan Recognition Protein-L Is an N-Acetylmuramoyl-L-alanine Amidase
J. Biol. Chem.,
December 5, 2003;
278(49):
49044 - 49052.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Vodovotz, Shubing Liu, C. McCloskey, R. Shapiro, A. Green, and T. R. Billiar
The hepatocyte as a microbial product-responsive cell
Innate Immunity,
October 1, 2001;
7(5):
365 - 373.
[Abstract]
[PDF]
|
|
|
|
|
|
|
I. A. Schrijver, M. van Meurs, M.-J. Melief, C. Wim Ang, D. Buljevac, R. Ravid, M. P. Hazenberg, and J. D. Laman
Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis
Brain,
August 1, 2001;
124(8):
1544 - 1554.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Persson, P. Andersson, M. Bodelsson, M. Laurell, J. Malm, and A. Egesten
Bactericidal Activity of Human Eosinophilic Granulocytes against Escherichia coli
Infect. Immun.,
June 1, 2001;
69(6):
3591 - 3596.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X Zhang, M Rimpilainen, and P Toivanen
Characterisation of Eubacterium cell wall: peptidoglycan structure determines arthritogenicity
Ann Rheum Dis,
March 1, 2001;
60(3):
269 - 274.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Simelyte, M. Rimpilainen, L. Lehtonen, X. Zhang, and P. Toivanen
Bacterial Cell Wall-Induced Arthritis: Chemical Composition and Tissue Distribution of Four Lactobacillus Strains
Infect. Immun.,
June 1, 2000;
68(6):
3535 - 3540.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Zhang, M. Rimpilainen, E. Simelyte, and P. Toivanen
What determines arthritogenicity of bacterial cell wall? A study on Eubacterium cell wall-induced arthritis
Rheumatology,
March 1, 2000;
39(3):
274 - 282.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
